Discontinued — last reported Q4 '14
Thermo Fisher Scientific Investment Purchases decreased by 20.0% to $32.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 97.6%, from $1.33B to $32.00M. Over 3 years (FY 2022 to FY 2025), Investment Purchases shows an upward trend with a 94.6% CAGR.
High volume indicates the company has significant excess cash from operations that it is parking in interest-bearing or liquid instruments.
The total cash spent on purchasing liquid financial instruments, such as corporate bonds, government securities, or othe...
Cash-rich companies like Microsoft and Apple frequently move billions between cash and short-term investment accounts.
cf_purchases_of_investments| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.00M | $13.00M | $13.00M | $13.00M | $2.00M | $186.00M | $12.00M | $8.00M | $1.76B | $20.00M | $287.00M | $1.33B | $264.00M | $47.00M | $40.00M | $32.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -84.6% | >999% | -93.5% | -33.3% | >999% | -98.9% | >999% | +363.8% | -80.2% | -82.2% | -14.9% | -20.0% |
| YoY Change | — | — | — | — | -84.6% | >999% | -7.7% | -38.5% | >999% | -89.2% | >999% | >999% | -85.0% | +135.0% | -86.1% | -97.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.